These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
546 related items for PubMed ID: 23600649
1. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery. Sharma S, Lohan S, Murthy RS. Drug Dev Ind Pharm; 2014 Jul; 40(7):869-78. PubMed ID: 23600649 [Abstract] [Full Text] [Related]
3. Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting. Jose S, Ansa CR, Cinu TA, Chacko AJ, Aleykutty NA, Ferreira SV, Souto EB. Int J Pharm; 2013 Jan 30; 441(1-2):516-26. PubMed ID: 23147411 [Abstract] [Full Text] [Related]
4. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats. Khan S, Patil K, Bobade N, Yeole P, Gaikwad R. J Drug Target; 2010 Apr 30; 18(3):223-34. PubMed ID: 20030503 [Abstract] [Full Text] [Related]
5. Development, characterization and application of in situ gel systems for intranasal delivery of tacrine. Qian S, Wong YC, Zuo Z. Int J Pharm; 2014 Jul 01; 468(1-2):272-82. PubMed ID: 24709220 [Abstract] [Full Text] [Related]
6. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery. Hao J, Zhao J, Zhang S, Tong T, Zhuang Q, Jin K, Chen W, Tang H. Colloids Surf B Biointerfaces; 2016 Nov 01; 147():376-386. PubMed ID: 27566226 [Abstract] [Full Text] [Related]
7. Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route. Gabal YM, Kamel AO, Sammour OA, Elshafeey AH. Int J Pharm; 2014 Oct 01; 473(1-2):442-57. PubMed ID: 25062866 [Abstract] [Full Text] [Related]
8. PLGA Nanoparticles Based Mucoadhesive Nasal In Situ Gel for Enhanced Brain Delivery of Topiramate. Tanna V, Vora A, Shah P, Nair AB, Shah J, Sawarkar SP. AAPS PharmSciTech; 2024 Sep 05; 25(7):205. PubMed ID: 39237656 [Abstract] [Full Text] [Related]
14. Increased brain radioactivity by intranasal P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels. Perez AP, Mundiña-Weilenmann C, Romero EL, Morilla MJ. Int J Nanomedicine; 2012 Sep 05; 7():1373-85. PubMed ID: 22457595 [Abstract] [Full Text] [Related]
15. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis. Saini D, Fazil M, Ali MM, Baboota S, Ali J. Drug Deliv; 2015 Sep 05; 22(6):823-36. PubMed ID: 24725026 [Abstract] [Full Text] [Related]
16. Investigating the cubosomal ability for transnasal brain targeting: In vitro optimization, ex vivo permeation and in vivo biodistribution. Abdelrahman FE, Elsayed I, Gad MK, Badr A, Mohamed MI. Int J Pharm; 2015 Jul 25; 490(1-2):281-91. PubMed ID: 26026251 [Abstract] [Full Text] [Related]
17. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Zaki NM, Awad GA, Mortada ND, Abd Elhady SS. Eur J Pharm Sci; 2007 Dec 25; 32(4-5):296-307. PubMed ID: 17920822 [Abstract] [Full Text] [Related]
18. Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain. Ved PM, Kim K. Int J Pharm; 2011 Jun 15; 411(1-2):1-9. PubMed ID: 21356294 [Abstract] [Full Text] [Related]